Christopher Cano
2021
In 2021, Christopher Cano earned a total compensation of $664.2K as COO and VP of Business Development at TFF Pharmaceuticals, a 52% decrease compared to previous year.
Compensation breakdown
| Bonus | $62,250 |
|---|---|
| Option Awards | $276,920 |
| Salary | $325,000 |
| Total | $664,170 |
Cano received $325K in salary, accounting for 49% of the total pay in 2021.
Cano also received $62.3K in bonus and $276.9K in option awards.
Rankings
In 2021, Christopher Cano's compensation ranked 10,058th out of 12,415 executives tracked by ExecPay. In other words, Cano earned more than 19.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,058 out of 12,415 | 19th |
Division Manufacturing | 4,453 out of 5,505 | 19th |
Major group Chemicals And Allied Products | 1,985 out of 2,375 | 16th |
Industry group Drugs | 1,764 out of 2,096 | 16th |
Industry Pharmaceutical Preparations | 1,316 out of 1,546 | 15th |
Source: SEC filing on September 21, 2022.
Cano's colleagues
We found two more compensation records of executives who worked with Christopher Cano at TFF Pharmaceuticals in 2021.